Mevidalen

LY3154207 · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Mevidalen, covering 2025-12-17 to 2025-12-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Mevidalen (LY3154207) in Participants With Alzheimer's Disease [Phase 2]